Neurocrine Biosciences, 10% Owner of Voyager Therapeutics VYGR, has filed 1 purchase and 0 sales on the open market. The latest trade was on 23/02/23.

Neurocrine Biosciences

10% Owner

Company

Voyager Therapeutics VYGR

First filing

23/02/24

Trades

1 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

23/02/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Voyager TherapeuticsVYGR	Open-market buy	23/02/23	23/02/24	4,395,588 sh	$8.88	$39,032,821.44	+105.2%